Adicet Bio
ACET
#10726
Rank
HK$0.15 B
Marketcap
HK$16.78
Share price
-13.01%
Change (1 day)
271.59%
Change (1 year)

Adicet Bio (ACET) - Cash on Hand

Cash on Hand as of June 2026 : HK$0.92 Billion

According to Adicet Bio's latest financial reports the company has HK$0.92 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adicet Bio - Cash on Hand chart (from 2019 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$1.23 B-9.88%
2024-12-31HK$1.36 B9.73%
2023-12-31HK$1.24 B-38.04%
2022-12-31HK$2.01 B-6.98%
2021-12-31HK$2.16 B195.06%
2020-12-31HK$0.73 B50.93%
2019-12-31HK$0.48 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
HK$70.35 B 7,493.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$91.69 B 9,797.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$55.97 B 5,941.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$28.65 B 2,992.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Hawkins
HWKN
HK$55.65 M-93.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Quaker Houghton
KWR
HK$1.21 B 31.22%๐Ÿ‡บ๐Ÿ‡ธ USA